In a patient with elevated hematocrit who is taking iron supplements and has normal transferrin saturation and ferritin, what is the likely cause and appropriate management?

Elevated Hematocrit with Iron Supplementation and Normal Iron Studies

Stop iron supplementation immediately and investigate the underlying cause of elevated hematocrit, as normal transferrin saturation and ferritin indicate this is NOT iron deficiency anemia but rather a primary polycythemic process that iron is inappropriately exacerbating.

Clinical Reasoning

The clinical picture you describe—elevated hematocrit with normal transferrin saturation (TSAT) and ferritin while on iron supplementation—represents a critical diagnostic scenario that requires immediate action:

Why Iron Should Be Stopped

• Normal iron parameters exclude iron deficiency: With normal TSAT and ferritin, there is no physiologic indication for iron supplementation 1
• Risk of iron overload: Continuing iron in the absence of deficiency can lead to tissue iron accumulation with serious consequences including myocardial dysfunction, liver cirrhosis, and hepatocellular carcinoma 2
• Inappropriate erythrocytosis: Iron supplementation is driving red cell production in someone who doesn't need it, potentially worsening hyperviscosity 3

Differential Diagnosis to Pursue

The elevated hematocrit with normal iron studies suggests:

1. Primary polycythemia vera - Check JAK2 mutation, erythropoietin level
2. Secondary erythrocytosis - Evaluate for:
   • Chronic hypoxemia (sleep apnea, COPD, high altitude, cyanotic heart disease)
   • Renal pathology (renal artery stenosis, cysts, tumors producing erythropoietin)
   • Other EPO-secreting tumors (hepatocellular carcinoma, cerebellar hemangioblastoma)
3. Relative polycythemia - Dehydration, diuretic use, smoking

Immediate Management Algorithm

Step 1: Discontinue iron supplementation

• No indication with normal TSAT and ferritin 4, 5
• Risk of harm exceeds any theoretical benefit

Step 2: Assess for hyperviscosity symptoms

• Headache, visual disturbances, dizziness, poor concentration
• Pruritus after bathing (suggests polycythemia vera)
• Thrombotic events or bleeding 6, 7

Step 3: Check hematocrit level and hydration status

• If hematocrit >65% with symptoms: consider therapeutic phlebotomy with equal volume replacement 6
• First ensure adequate hydration (oral or IV fluids) 7
• Phlebotomy should only be done after rehydration if symptoms persist 7

Step 4: Obtain diagnostic workup

• Complete blood count with differential (look for leukocytosis, thrombocytosis suggesting PV)
• Erythropoietin level (low in PV, high in secondary causes)
• JAK2 V617F mutation
• Oxygen saturation, arterial blood gas
• Renal ultrasound if secondary causes suspected
• Sleep study if clinically indicated

Critical Pitfalls to Avoid

Do NOT continue iron "because the patient is anemic" - The elevated hematocrit indicates the opposite problem. If there was prior anemia that prompted iron supplementation, the clinical picture has fundamentally changed 8.

Do NOT perform routine phlebotomy without identifying the cause - Repeated phlebotomies without addressing the underlying driver can lead to iron deficiency with persistent erythrocytosis, creating a dangerous microcytic polycythemia 3, 8. This is particularly problematic as it reduces oxygen-carrying capacity without lowering viscosity.

Do NOT assume this is hemochromatosis - While hemochromatosis causes iron overload, it typically presents with elevated TSAT (>45-50%) and ferritin, not normal values 9, 5, 10. The normal TSAT effectively excludes hereditary hemochromatosis as the primary issue.

Special Considerations

If the patient has chronic hypoxemia (cyanotic heart disease, severe lung disease):

• The elevated hematocrit may be physiologically appropriate secondary erythrocytosis 7, 3
• Iron supplementation in this context is particularly dangerous as it can drive hematocrit to dangerous levels (>65-70%) 6, 3
• Management focuses on treating underlying hypoxemia, not the compensatory erythrocytosis
• Phlebotomy is rarely indicated unless hematocrit >65% with symptoms after adequate hydration 7

Monitoring After Iron Cessation

• Recheck CBC in 4-6 weeks to assess hematocrit trajectory
• Monitor TSAT and ferritin to ensure they remain normal
• If hematocrit normalizes after stopping iron, this confirms iatrogenic polycythemia
• If hematocrit remains elevated, proceed with full polycythemia workup

The combination of elevated hematocrit with normal iron parameters while on supplementation represents inappropriate iron administration that must be stopped immediately to prevent complications of both polycythemia and potential iron overload 4, 2.